USA: Judge sends to trial 1,200 lawsuits against pharmaceutical cos. alleging failure to inform patients & doctors of drug side effects

Author: Beasley Allen, CISION PR Newswire (USA), Published on: 13 March 2018

"Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials", 8 Mar 2018

A federal district judge in New Orleans has ordered that 1,200 product defect lawsuits against leading prescription anticoagulant Xarelto be prepared for trial in federal courts across the country.  The decision by U.S. District Judge Eldon Fallon marks a significant milestone in multidistrict litigation (MDL) filed by thousands of individuals who have suffered serious medical complications after taking Xarelto.  In conjunction with his ruling to prepare 1,200 cases for remand to their original trial courts, Judge Fallon ordered the lawsuits to be selected in two groups of 600 cases...Once selected, each lawsuit will be subject to case-specific discovery.  The Xarelto MDL includes a total of more than 18,000 lawsuits...The lawsuits charge that Xarelto developers Bayer Healthcare...and Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson..., downplayed Xarelto's risks of serious medical complications and aggressively marketed the drug as an alternative for warfarin in patients needing blood thinners to reduce the risk of dangerous clots.  The lawsuits charge that doctors and patients were not fully informed of the risks, which have resulted in thousands of life-threatening complications...

Read the full post here

Related companies: Bayer Janssen Pharmaceutica (part of Johnson & Johnson)